Abiopharma

Creative Realities Reports Fiscal 2026 Second Quarter Results

Monro, Inc. Declares Quarterly Cash Dividend

MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury

Indonesia Energy Corporation Reports Progress on Drilling of K-29 Well

Reborn Coffee Signs $20 Million Annual Supply Agreement with The Mighty Oak, Strengthening Its Revenue Base and Profitability Through the Conversion of Existing Supply Volume

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates

Bragg Gaming Group Reports Second Quarter 2026 Financial Results

Rio2 Reports Q2 2026 Financial and Operating Results and Webinar

UTStarcom Announces Finance Leadership Changes

DEFSEC Technologies Inc. Announces Third Quarter Fiscal 2026 Results

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000950103-26-012291 <b>Size:</b> 83 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023654 <b>Size:</b> 614 KB

New Form SCHEDULE 13G/A - Genpact LTD <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000188 <b>Size:</b> 8 KB

Asset Acquisitions and Disposals: ANNOUNCEMENT PURSUANT TO RULE 706A OF THE LISTING MANUAL